KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study.
Nakano Y, Kitago M, Matsuda S, Nakamura Y, Fujita Y, Imai S, Shinoda M, Yagi H, Abe Y, Hibi T, Fujii-Nishimura Y, Takeuchi A, Endo Y, Itano O, Kitagawa Y.
Nakano Y, et al. Among authors: imai s.
Br J Cancer. 2018 Mar 6;118(5):662-669. doi: 10.1038/bjc.2017.479. Epub 2018 Jan 23.
Br J Cancer. 2018.
PMID: 29360815
Free PMC article.
Clinical Trial.